Literature DB >> 15586015

Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease.

Raimund Hirschberg1, Shinong Wang.   

Abstract

PURPOSE OF REVIEW: There are ongoing debates as to the role and mechanisms of proteinuria in tubulointerstitial fibrogenesis. Moreover, recent experimental findings have allowed for further insights into mediators and interactions between cells in the renal interstitium during fibrogenesis. RECENT
FINDINGS: Proteinuria or albuminuria are likely just markers for the glomerular ultrafiltration and tubular actions of ultrafiltered, biologically active growth factors which 'activate' tubular cells causing basolateral secretion of chemokines and cytokines. Chemokines attract and activate macrophages. Tubular cell-derived platelet-derived growth factor (PDGF) and macrophage-derived transforming growth factor-beta cause fibroblast proliferation. Several growth factors contribute to their transition into extracellular matrix-producing myofibroblasts. This cascade of events provides targets for some currently available and several novel therapies.
SUMMARY: Albuminuria or glomerular proteinuria appear to be markers but ultrafiltered, bioactive growth factors are culprits in proteinuria-associated interstitial fibrosis. Interactions of tubular cells with macrophages and fibroblasts in the interstitium via defined growth factor/cytokines provide opportunities for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15586015     DOI: 10.1097/00041552-200501000-00008

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  22 in total

Review 1.  The African American Study of Kidney Disease: do these results indicate that 140/90 mm hg is good enough?

Authors:  Mahboob Rahman; Ashraf El-Meanawy; Joseph Romanello
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 2.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 3.  ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5.

Authors:  Leigh Wellhauser; Christina D'Antonio; Christine E Bear
Journal:  Pflugers Arch       Date:  2010-01-05       Impact factor: 3.657

4.  Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Philip M Murphy
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Stop chronic kidney disease progression: Time is approaching.

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-05-06

Review 6.  The proximal tubule in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 7.  Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Annu Rev Physiol       Date:  2012       Impact factor: 19.318

Review 8.  Managing kidney disease with blood-pressure control.

Authors:  Elke Wühl; Franz Schaefer
Journal:  Nat Rev Nephrol       Date:  2011-06-21       Impact factor: 28.314

Review 9.  Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Authors:  Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

Review 10.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.